MedPath

Body Surface Point and EEG Change Observation during Menstruatio

Not Applicable
Completed
Conditions
Not Applicable
Registration Number
KCT0004507
Lead Sponsor
Korea Institute of Oriental Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
20
Inclusion Criteria

1. Women of childbearing age over 19
2. menstrual pain intensity assessment tool” tot10: The tot10 value is the average of MVRS, VRS, VAS, q9-1, and q9-3 converted into 10 points in the questionnaire for menstrual pain intensity
Subjects with over 4 points
3. Subjects who were clearly briefed on the purpose and characteristics of the study and who subsequently agreed to participate and signed the written consent form

Exclusion Criteria

1. Individuals with neurological disorders such as epilepsy, meningitis, encephalitis, cerebrovascular disease, multiple sclerosis, tic disorder, headache, peripheral nerve disorder, and sensory nerve disorder
2. Individuals with chronic diseases such as hypertension and diabetes
(The criterion for abnormal blood pressure is the average systolic pressure of over 140 mmHg or the average diastolic pressure of over 90 mmHg, when the pressure is measured twice at more than 2-minute intervals using an automatic blood pressure gauge after resting in sitting position for at least 5 minutes; arrhythmia is observed in the PPG test.)
3. Individuals with allergies to skin-contact materials for research such as metals and electrode paste
4. Individuals with burns, wounds, and skin disorders on the stimulation site
5. Individuals with history of general anesthesia within a year
6. Individuals taking medication including analgesics, psychotherapy drugs for depression, and drugs for diabetes and hypertension and neurological disorders within 1 month
7. Individuals with irregular menstrual cycle of over 10 days
8. Individuals with history of being diagnosed with uterine myoma, endometriosis, ovarian cyst, polycystic ovarian syndrome, and pelvic inflammatory disease that can induce menstrual pain before participating in the study
9. Individuals with polymenorrhea (less than 21 days of menstrual period) or oligomenorrhea (more than 35 days of menstrual period)
10. Individuals who are considered not to have the ability to fill out the documents related to study performance
11. Other individuals who are considered inappropriate for study participation

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Differences in the intensity of pressure stimulation of VAS 4 at each stimulation point (response point, non-response point screening)
Secondary Outcome Measures
NameTimeMethod
Differences in brain wave patterns when the response point is stimulated on the somatosensory cortex;Differences in brain wave pattern changes when the response point is stimulated on the somatosensory cortex and when the non-response point is stimulated on the somatosensory cortex
© Copyright 2025. All Rights Reserved by MedPath